Skip to content

Skin Irritation Potential of Bioavenues Eden?s Gradeur Alpha Radiance Serum

A Clinical Study to Evaluation Of Skin Irritation Potential of Bioavenues Eden?s Gradeur Alpha Radiance Serum On Healthy Human Volunteers - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/09/074181
Enrollment
24
Registered
2024-09-23
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Finn Chamber: Each patch contains 40 microgram/ microliters of 1.Eders Gradeur Alpha Radiance Serum, 2. Negative control(0.9% NaCl, 3.Positive Control- 1% SLS) Route of Administration:

Sponsors

Bio Avenues Redefining Cosmeceuticals
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Voluntary man or women between 18 and 45 years. 2. Photo type III to V. 3. Having apparently healthy skin on test area 4. For whom the investigator considers that the compliance will be correct. 5. Cooperating, informed of the need and duration of the examinations and ready to comply with protocol procedures. 6. Having signed a Consent Form. 7. Should be able to read and write (in English, Hindi or local language). 8. Having valid proof of identity and age.

Exclusion criteria

Exclusion criteria: 1. Pregnant or nursing mothers 2.Scars, excessive terminal hair or tattoo on the studied area 3.Henna tattoo anywhere on the body (in case of studies involving hair dyes) 4.Dermatological infection or pathology on the level of studied area 5.Hypersensitivity, allergy antecedent (to any cosmetic product, raw material or hair dye) 6.Any clinically significant systemic or cutaneous disease, which may interfere with study treatment or procedures 7.Chronic illness which may influence the outcome of the study 8.Subjects on any medical treatment either systemic or topical which may interfere with the performance of the study treatment (presently or in the past 1 month) 9.Subject in an exclusion period or participating in another food, cosmetic or therapeutic trial.

Design outcomes

Primary

MeasureTime frame
Change in Skin Irritation Score-erythema & oedemaTimepoint: Day 0, Day 2 and Day 8

Secondary

MeasureTime frame
Not ApplicableTimepoint: Not Applicable

Countries

India

Contacts

Public ContactPuneet Mittal

CCFT Laboratories

puneetmittal@mgcts.org8937015757

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026